-The Hindu In a society where self-worth is increasingly equated with sexual attractiveness, there are plenty of products that target both men and women. So why whine about the 18 Again ad? VAISHNA ROY I remember an old issue of MAD in which Dave Berg imagined a society where the nose defined sexuality. It had a hilarious sketch of a woman on a beach with a strip of cloth coyly covering her...
More »SEARCH RESULT
Food, the new crisis-CP Chandrasekhar
-Frontline A recession-hit world is only just waking up to the prospect of the coming food crisis resulting in a period of political turmoil with unexpected consequences. For the third time in five years, the world is braced for another food crisis. Bad weather conditions are leading to projections of major production shortfalls in some of the world’s leading food suppliers. Substantially reduced access and sharp price increases are, therefore, expected to...
More »Reforms, competition in distribution and end to coal monopoly only antidotes to power failures-Arvind Panagariya
-The Economic Times The power failure in India on July 30-31 was big news in US media. When the radio and TV stations began calling with the question whether this spelt the end to India's claims to global-power status, my first reaction was to remind them that a similar failure of the grid in 2003 had drowned the entire Northeast and Midwest in the US and Ontario in Canada into darkness. But,...
More »BJP-led Chhattisgarh, Rajasthan opposed competitive bidding-Sujay Mehdudia
-The Hindu The Bharatiya Janata Party and other opposition parties are crying foul over Prime Minister Manmohan Singh’s alleged involvement in the coal blocks allocation scam but the BJP-led Chhattisgarh and Rajasthan governments themselves were among the strong opponents to a transparent process of competitive bidding, and pitched for continuing the policy of allocation of coal blocks. Documents with The Hindu show that the BJP governments were against putting in place an...
More »Lack of compensation norms for clinical trials results in exploitation of poor patients-Khomba Singh
-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »